These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1615668)

  • 1. Drug company marketing in the groves of academe.
    Schwartz TB
    West J Med; 1992 Jun; 156(6):660-1. PubMed ID: 1615668
    [No Abstract]   [Full Text] [Related]  

  • 2. Must "no see" always mean a "no know"?
    Gamble GL
    PM R; 2009 Jan; 1(1):87-8. PubMed ID: 19627879
    [No Abstract]   [Full Text] [Related]  

  • 3. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure.
    Hensley S
    Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription for conflict. AMA accepts funding from drug firms for campaign.
    Romano M
    Mod Healthc; 2001 Jun; 31(25):14. PubMed ID: 11436381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug industry and bribes].
    Annertz M
    Lakartidningen; 2004 Apr; 101(15-16):1436. PubMed ID: 15146680
    [No Abstract]   [Full Text] [Related]  

  • 6. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketing Rx&D.
    Ogle K
    CMAJ; 2003 May; 168(10):1238-9; discussion 1239. PubMed ID: 12743055
    [No Abstract]   [Full Text] [Related]  

  • 8. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 9. Ties that bind? The web of CME and medical industry profit.
    Busby J
    Tex Med; 1991 Aug; 87(8):38-46. PubMed ID: 1925989
    [No Abstract]   [Full Text] [Related]  

  • 10. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?].
    Eckardt VF
    Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between paediatricians and commerce.
    Hilliard T; Chambers T
    Paediatr Respir Rev; 2006 Mar; 7(1):54-9. PubMed ID: 16473818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Commercialization of the medical research is a reality. What is the limit?].
    Naeser K
    Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105
    [No Abstract]   [Full Text] [Related]  

  • 13. Singapore infectious diseases comes of age.
    Allen DM
    Singapore Med J; 1994 Jun; 35(3):314-5. PubMed ID: 7997913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug indoctrination or education? You are member of the county council's political committee].
    Andrén-Sandberg A
    Lakartidningen; 2003 Oct; 100(42):3328-32. PubMed ID: 14619046
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry sponsorship of scientific meetings: peaks and troughs.
    Isaacs D
    J Paediatr Child Health; 2012 Jul; 48(7):547. PubMed ID: 22758896
    [No Abstract]   [Full Text] [Related]  

  • 16. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug companies and continuing education].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2043. PubMed ID: 16100551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug industry, the Medical Society and the others].
    Koren B
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2055. PubMed ID: 16100559
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
    Schetky DH
    Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharma industry--redressing the balance.
    Panay N; Fenton A
    Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.